Management of Esophageal Cancer

Current Problems in Surgery

Volumn 47, Issue 11, 2010, Pages 845-946

  Schuchert, Matthew J ^a   Luketich, James D ^a   Landreneau, Rodney J ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL; PHOTOFRIN; PROTON PUMP INHIBITOR;

ABLATION THERAPY; ARTICLE; BARIUM MEAL; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HISTORY OF MEDICINE; HUMAN; JEJUNUM INTERPOSITION; MINIMALLY INVASIVE SURGERY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK FACTOR; STOMACH FUNDOPLICATION; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; GASTROINTESTINAL ENDOSCOPY; INCIDENCE; PROCEDURES; UNITED STATES;

DIAGNOSTIC IMAGING; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; INCIDENCE; NEOPLASM STAGING; PROGNOSIS; UNITED STATES;

EID: 77957747835     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2010.07.002     Document Type: Article

References (306)

1. Qian Z. Investigation on esophageal cancer in the province of Xinjiang. Collected Papers of the Second Symposium on Esophageal Carcinoma. Chinese Acad Med Sci 1961, 74-78.
2. Brewer L.A. History of surgery of the esophagus. Am J Surg 1980, 139(6):730-743.
3. Eslick G.D. Esophageal cancer: a historical perspective. Gastroenterol Clin North Am 2009, 38(1):1-15. vii.
4. Monro A. The morbid anatomy of the human gullet, stomach, and intestines 1811, A. Constable, and Co, Edinburgh.
5. Kussmaul A. Zur geschicle der oesophago und Gastroskopie. Arch Klin Med 1898, 6:456.
6. Billroth T. Ueber die resection des oesophagus. Arch Klin Chir 1871, 13:65-69.
7. Czerny V. Neue operationen. Zentralbl Chir 1877, 4:433-434.
8. Kuczkowski J., Stankiewicz C., Kopacz A., et al. (1850-1905): pioneer of endoscopy and surgery of the sinuses, throat, and digestive tract. World J Surg Oct 2004, 28(10):1063-1067.
9. Torek F. The first successful resection of the thoracic portion of the oesophagus for carcinoma. Surg Gynecol Obstet 1913, 16:614-617.
10. Turner G. Excision of the thoracic h{double-struck}sophagus for carcinoma: with construction of an extra-thoracic gullet. Lancet 1933, 222(5754):1315-1316.
11. Ohsawa T. The surgery of the esophagus. Arch Jpn Chir 1933, 10:605.
12. Lewis I. The surgical treatment of carcinoma of the esophagus with special reference to a new operation for growths of the middle third. Br J Surg 1946, 34:18-31.
13. Sweet R. Transthoracic resection of the esophagus and stomach for carcinoma: analysis of the post-operative complications, causes of death and late results of operation. Ann Surg 1945, 121(3):272-284.
14. Garlock J. The surgical treatment of carcinoma of the thoracic esophagus. Surg Gynecol Obstet 1938, 66:534-548.
15. McKeown K.C. Total three-stage oesophagectomy for cancer of the oesophagus. Br J Surg Apr 1976, 63(4):259-262.
16. Orringer M.B., Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg Nov 1978, 76(5):643-654.
17. DePaula A.L., Hashiba K., Ferreira E.A., et al. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 1995, 5(1):1-5.
18. Swanstrom L.L., Hansen P. Laparoscopic total esophagectomy. Arch Surg Sept 1997, 132(9):943-947. Discussion 947-9.
19. Luketich J.D., Alvelo-Rivera M., Buenaventura P.O., et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003, 238(4):486-494. Discussion 494-5.
20. Tileston W. Peptic ulcer of the esophagus. Am J Med Sci 1906, 132:240-265.
21. Cameron A.J. The history of Barrett esophagus. Mayo Clin Proc 2001, 76(1):94-96.
22. Barrett N.R. Chronic peptic ulcer of the oesophagus and "oesophagitis". Br J Surg 1950, 38(150):175-182.
23. Bosher L.H., Taylor F.H. Heterotopic gastric mucosa in the esophagus with ulceration and stricture formation. J Thorac Surg 1951, 21(3):306-312.
24. Morson B.C., Belcher J.R. Adenocarcinoma of the oesophagus and ectopic gastric mucosa. Br J Cancer Jun 1952, 6(2):127-130.
25. Allison P.R., Johnstone A.S. The oesophagus lined with gastric mucous membrane. Thorax Jun 1953, 8(2):87-101.
26. Barrett N.R. The lower esophagus lined by columnar epithelium. Surgery 1957, 41(6):881-894.
27. Moersch R.N., Ellis F.H., McDonald D.J. Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet 1959, 108(4):476-484.
28. Cameron A.J., Ott B.J., Payne W.S. Barrett esophagus: incidence of adenocarcinoma during long term follow-up. Gut 1983, 24:A1007-A1008.
29. Iascone C., DeMeester T.R., Little A.G., et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 1983, 118(5):543-549.
30. Naef A.P., Savary M. Conservative operations for peptic esophagitis with stenosis in columnar-lined lower esophagus. Ann Thorac Surg 1972, 13(6):543-551.
31. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol May 10 2006, 24(14):2137-2150.
32. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 2008, 58(2):71-96.
33. Eloubeidi M.A., Desmond R., Arguedas M.R., et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002, 95(7):1434-1443.
34. Yang P.C., Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer 1988, 61(3):612-617.
35. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265(10):1287-1289.
36. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83(10):2049-2053.
37. Eslick G.D. Epidemiology of esophageal cancer. Gastroenterol Clin North Am 2009, 38(1):17-25. vii.
38. Yu M.C., Garabrant D.H., Peters J.M., et al. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus. Cancer Res 1988, 48(13):3843-3848.
39. Smoking and Health: A Report of the Surgeon General [Rockville, MD] 1979, Office on Smoking and Health, USA, Surgeon General's Advisory Committee on Smoking and HealthSurgeon General's Advisory Committee on Smoking and Health, U.S. Dept. of Health, Education, and Welfare, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health; Washington, DC: for sale by the Supt. of Docs., U. S. Govt. Printing Office.
40. Reducing the health consequences of smoking: 25 years of progress: a report of the Surgeon General: 1989 executive summary 1989, United States. Public Health Service. Office of the Surgeon General, United States. Office on Smoking and Health, U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, Rockville, MD.
41. Notani P.N. Role of alcohol in cancers of the upper alimentary tract: use of models in risk assessment. J Epidemiol Community Health 1988, 42(2):187-192.
42. Kamangar F., Chow W.H., Abnet C.C., et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009, 38(1):27-57. vii.
43. Guo W.D., Li J.Y., Blot W.J., et al. Correlations of dietary intake and blood nutrient levels with esophageal cancer mortality in China. Nutr Cancer 1990, 13(3):121-127.
44. Jaskiewicz K., Marasas W.F., Rossouw J.E., et al. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer 1988, 62(12):2635-2639.
45. Lu S.H., Ohshima H., Fu H.M., et al. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for esophageal cancer in Northern China: endogenous formation of nitrosoproline and its inhibition by vitamin C. Cancer Res 1986, 46(3):1485-1491.
46. Burrell R.J., Roach W.A., Shadwell A. Esophageal cancer in the Bantu of the Transkei associated with mineral deficiency in garden plants. J Natl Cancer Inst 1966, 36(2):201-209.
47. Amer M.H., El-Yazigi A., Hannan M.A., et al. Water contamination and esophageal cancer at Gassim region, Saudi Arabia. Gastroenterology 1990, 98(5 Pt 1):1141-1147.
48. Wychulis A.R., Woolam G.L., Andersen H.A., et al. Achalasia and carcinoma of the esophagus. JAMA 1971, 215(10):1638-1641.
49. Iyomasa S., Kato H., Tachimori Y., et al. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol 1990, 20(1):99-106.
50. Shimizu T., Matsui T., Kimura O., et al. Radiation-induced esophageal cancer: a case report and a review of the literature. Jpn J Surg 1990, 20(1):97-100.
51. Atabek U., Mohit-Tabatabai M.A., Rush B.F., et al. Impact of esophageal screening in patients with head and neck cancer. Am Surg 1990, 56(5):289-292.
52. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004, 85:1-334. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
53. Bjorge T., Hakulinen T., Engeland A., et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997, 57(18):3989-3992.
54. Selby W.S., Gallagher N.D. Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci 1979, 24(9):684-688.
55. Arnott S.J., Pearson J.G., Finlayson N.D., et al. The association of squamous oesophageal cancer and thyroid disease. Br J Cancer 1971, 25(1):33-36.
56. Gammon M.D., Schoenberg J.B., Ahsan H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997, 89(17):1277-1284.
57. Lagergren J., Bergstrom R., Lindgren A., et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000, 85(3):340-346.
58. Lagergren J., Bergstrom R., Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999, 130(11):883-890.
59. Hampel H., Abraham N.S., El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143(3):199-211.
60. Kubo A., Corley D.A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(5):872-878.
61. Schwindt W.D., Bernhardt L.C., Johnson A.M. Tylosis and intrathoracic neoplasms. Chest 1970, 57(6):590-591.
62. Howel-Evans W., McConnell C.R., Clarke C.A., et al. Carcinoma of the oesophagus with keratosis palmaris et plantaris (tylosis): a study of two families. Q J Med 1958, 27(107):413-429.
63. Hamoui N., Peters J.H., Schneider S., et al. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg Jul 2004, 139(7):712-716. Discussion 716-7.
64. Peters J.H., DeMeester T.R. Esophagus: anatomy physiology and gastroesophageal reflux disease. Surgery: Scientific Principles and Practice 2001, Lippincott, Williams and Wilkins, Philadelphia, PA. 3rd edition. L.J. Greenfield, M.W. Mulholland, K.T. Oldham (Eds.).
65. Souza R.F., Shewmake K., Pearson S., et al. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2004, 287(4):G743-G748.
66. Theisen J., Peters J.H., Stein H.J. Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus. World J Surg 2003, 27(9):1018-1020.
67. Wetscher G.J., Hinder R.A., Kretchmar D., et al. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996, 41(11):2166-2173.
68. Wetscher G.J., Hinder R.A., Smyrk T., et al. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 1999, 44(6):1132-1135.
69. Yamashita Y., Homma K., Kako N., et al. Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats. J Gastrointest Surg 1998, 2(4):350-355.
70. Jenkins G.J., D'Souza F.R., Suzen S.H., et al. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett's oesophagus. Carcinogenesis 2007, 28(1):136-142.
71. Bremner C.G., Lynch V.P., Ellis F.H. Barrett's esophagus: congenital or acquired?. An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970, 68(1):209-216.
72. Szentpali K., Szell M., Paszt A., et al. Simultaneous adeno- and squamous cell carcinoma with different phenotypic profiles in a rat model of chronic gastroesophageal reflux. Dis Esophagus 2007, 20(4):305-310.
73. Shackney S.E., Smith C.A., Pollice A., et al. Genetic evolutionary staging of early non-small cell lung cancer: the;P53 → HER-2/NEU → ras sequence. J Thorac Cardiovasc Surg 1999, 118(2):259-267.
74. Maley C.C. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett 2007, 245(1-2):22-32.
75. Maley C.C., Galipeau P.C., Li X., et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 2004, 64(10):3414-3427.
76. Izzo J.G., Luthra R., Wu T.T., et al. Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol 2007, 34(2 suppl 1):S2-S6.
77. Hameeteman W., Tytgat G.N., Houthoff H.J., et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989, 96(5 Pt 1):1249-1256.
78. Raja S., Finkelstein S.D., Baksh F.K., et al. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. Ann Thorac Surg 2001, 72(4):1130-1135.
79. Wang S., Zhan M., Yin J., et al. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 2006, 25(23):3346-3356.
80. Greenawalt D.M., Duong C., Smyth G.K., et al. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma. Int J Cancer 2007, 120(9):1914-1921.
81. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998, 93(7):1028-1032. The Practice Parameters Committee of the American College of Gastroenterology.
82. Cameron A.J., Lomboy C.T., Pera M., et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995, 109(5):1541-1546.
83. Shaheen N.J., Crosby M.A., Bozymski E.M., et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 2000, 119(2):333-338.
84. Eloubeidi M.A., Provenzale D. Does this patient have Barrett's esophagus?. The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1999, 94(4):937-943.
85. Endlicher E., Rummele P., Beer S., et al. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis. Endoscopy 2005, 37(11):1131-1135.
86. Malesci A., Savarino V., Zentilin P., et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc Dec 1996, 44(6):700-705.
87. Peters F.T., Ganesh S., Kuipers E.J., et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999, 45(4):489-494.
88. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992, 52(24):6735-6740.
89. Haigh C.R., Attwood S.E., Thompson D.G., et al. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003, 124(3):615-625.
90. Bateman D.N., Colin-Jones D., Hartz S., et al. Mortality study of 18 000 patients treated with omeprazole. Gut Jul 2003, 52(7):942-946.
91. Chow W.H., Finkle W.D., McLaughlin J.K., et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995, 274(6):474-477.
92. Brand D.L., Ylvisaker J.T., Gelfand M., et al. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980, 302(15):844-848.
93. Gurski R.R., Peters J.H., Hagen J.A., et al. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 2003, 196(5):706-712. Discussion 712-3.
94. Oelschlager B.K., Barreca M., Chang L., et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 2003, 238(4):458-464. Discussion 464-6.
95. Zaninotto G., Cassaro M., Pennelli G., et al. Barrett's epithelium after antireflux surgery. J Gastrointest Surg 2005, 9(9):1253-1260. Discussion 1260-1.
96. Biertho L., Dallemagne B., Dewandre J.M., et al. Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc 2007, 21(1):11-15.
97. Zaninotto G., Rizzetto C. Surgical options and outcomes in Barrett's esophagus. Curr Opin Gastroenterol 2007, 23(4):452-455.
98. Hofstetter W.L., Peters J.H., DeMeester T.R., et al. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 2001, 234(4):532-538. Discussion 538-9.
99. Katz D., Rothstein R., Schned A., et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998, 93(4):536-541.
100. Ortiz A., Martinez de Haro L.F., Parrilla P., et al. Conservative treatment vs antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 1996, 83(2):274-278.
101. Spechler S.J., Lee E., Ahnen D., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001, 285(18):2331-2338.
102. Ye W., Chow W.H., Lagergren J., et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001, 121(6):1286-1293.
103. Corey K.E., Schmitz S.M., Shaheen N.J. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus?. A meta-analysis. Am J Gastroenterol 2003, 98(11):2390-2394.
104. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002, 97(8):1888-1895.
105. Rice T.W. Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 2006, 101(10):2177-2179.
106. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001, 120(7):1630-1639.
107. Reid B.J., Blount P.L., Feng Z., et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000, 95(11):3089-3096.
108. Levine D.S., Blount P.L., Rudolph R.E., et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol May 2000, 95(5):1152-1157.
109. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001, 120(7):1607-1619.
110. Dar M.S., Goldblum J.R., Rice T.W., et al. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?. Gut 2003, 52(4):486-489.
111. Schuchert M.J., McGrath K., Buenaventura P.O. Barrett's esophagus: diagnostic approaches and surveillance. Semin Thorac Cardiovasc Surg 2005, 17(4):301-312.
112. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62(4):488-498.
113. Wang K.K. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 1999, 49(3 Pt 2):S20-S23.
114. Abbas G., Pennathur A., Keeley S.B., et al. Laser ablation therapies for Barrett's esophagus. Semin Thorac Cardiovasc Surg 2005, 17(4):313-319.
115. Panjehpour M., Overholt B.F., Haydek J.M., et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 2000, 95(9):2177-2184.
116. Alef M.J., Schuchert M.J., Luketich J.D. Endoscopic treatment of Barrett's esopahagus. Current Surgical Therapy 2007, Mosby Elsevier, Philadelphia, PA. 9th edition. J. Cameron (Ed.).
117. Keeley S.B., Pennathur A., Gooding W., et al. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 2007, 14(8):2406-2410.
118. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007, 65(2):185-195.
119. Hazey J.W., Dunkin B.J., Melvin W.S. Changing attitudes toward endolumenal therapy. Surg Endosc 2007, 21(3):445-448.
120. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003, 57(7):854-859.
121. Giovannini M., Bories E., Pesenti C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004, 36(9):782-787.
122. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002, 14(10):1085-1091.
123. Buttar N.S., Wang K.K., Lutzke L.S., et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 2001, 54(6):682-688.
124. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007, 65(1):3-10.
125. Lopes C.V., Hela M., Pesenti C., et al. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 2007, 21(5):820-824.
126. Swisher S.G., Deford L., Merriman K.W., et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000, 119(6):1126-1132.
127. Luketich J.D., Nguyen N.T., Schauer P.R. Laparoscopic transhiatal esophagectomy for Barrett's esophagus with high grade dysplasia. JSLS 1998, 2(1):75-77.
128. Pierre A.F., Luketich J.D. Technique and role of minimally invasive esophagectomy for premalignant and malignant diseases of the esophagus. Surg Oncol Clin N Am 2002, 11(2):337-350.
129. Nguyen N.T., Schauer P., Luketich J.D. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery 2000, 127(3):284-290.
130. Pennathur A., Landreneau R.J., Luketich J.D. Surgical aspects of the patient with high-grade dysplasia. Semin Thorac Cardiovasc Surg 2005, 17(4):326-332.
131. Reed C.E. Surgical management of esophageal carcinoma. Oncologist 1999, 4(2):95-105.
132. Esophagus and esophagogastric junction. AJCC Cancer Staging Manual 2010, 103-115. American Joint Committee on Cancer, Springer, New York. 7th edition. S.B. Edge (Ed.).
133. Reed C.E., Mishra G., Sahai A.V., et al. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999, 67(2):319-321. Discussion 322.
134. Luketich J.D., Schauer P., Landreneau R., et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997, 114(5):817-821. Discussion 821-3.
135. Van Dam J., Rice T.W., Catalano M.F., et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993, 71(10):2910-2917.
136. Luketich J.D., Schauer P., Urso K., et al. Minimally invasive surgical biopsy confirms PET findings in esophageal cancer. Surg Endosc 1997, 11(12):1213-1215.
137. Luketich J.D., Schauer P.R., Meltzer C.C., et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997, 64(3):765-769.
138. Wren S.M., Stijns P., Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002, 137(9):1001-1006. Discussion 1006-7.
139. Murray G.F., Wilcox B.R., Starek P.J. The assessment of operability of esophageal carcinoma. Ann Thorac Surg 1977, 23(5):393-399.
140. Dagnini G., Caldironi M.W., Marin G., et al. Laparoscopy in abdominal staging of esophageal carcinoma. Report of 369 cases. Gastrointest Endosc 1986, 32(6):400-402.
141. Krasna M.J., McLaughlin J.S. Thoracoscopic lymph node staging for esophageal cancer. Ann Thorac Surg 1993, 56(3):671-674.
142. Krasna M.J., Reed C.E., Nedzwiecki D., et al. CALGB 9380: A prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Thorac Surg 2001, 71(4):1073-1079.
143. Kassis E.S., Nguyen N., Shriver S.P., et al. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. JSLS 1998, 2(4):331-336.
144. Luketich J.D., Kassis E.S., Shriver S.P., et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998, 66(5):1715-1718.
145. Krasna M.J., Mao Y.S., Sonett J.R., et al. P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg Dec 1999, 68(6):2021-2024. Discussion 2024-5.
146. Mathisen D.J., Grillo H.C., Wilkins E.W., et al. Transthoracic esophagectomy: a safe approach to carcinoma of the esophagus. Ann Thorac Surg 1988, 45(2):137-143.
147. Lerut T., De Leyn P., Coosemans W., et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992, 216(5):583-590.
148. Portale G., Hagen J.A., Peters J.H., et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 2006, 202(4):588-596. Discussion 596-8.
149. Orringer M.B., Marshall B., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007, 246(3):363-372. Discussion 372-4.
150. O'Reilly S., Forastiere A.A. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995, 6(6):519-521.
151. Sykes A.J., Burt P.A., Slevin N.J., et al. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol 1998, 48(1):15-21.
152. Choi N.C. Carcinoma of the esophagus. Clinical Radiation Oncology: Indications, Techniques, and Results 2000, Wiley-Liss, New York. 2nd edition. C.C. Wang (Ed.).
153. Earlam R., Cunha-Melo J.R. Oesophogeal squamous cell carcinoms. II. A critical view of radiotherapy. Br J Surg 1980, 67(7):457-461.
154. Shioyama Y., Nakamura K., Sasaki T., et al. Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience. Am J Clin Oncol 2005, 28(1):75-80.
155. Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326(24):1593-1598.
156. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999, 281(17):1623-1627. Radiation Therapy Oncology Group.
157. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose vs standard-dose radiation therapy. J Clin Oncol 2002, 20(5):1167-1174.
158. Pennathur A., Luketich J.D., Landreneau R.J., et al. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg 2008, 85(6):1930-1936. Discussion 1936-7.
159. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998, 339(27):1979-1984.
160. Roth J.A., Pass H.I., Flanagan M.M., et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988, 96(2):242-248.
161. Ancona E., Ruol A., Santi S., et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy vs surgery alone. Cancer 2001, 91(11):2165-2174.
162. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002, 359(9319):1727-1733. MRC.
163. Boige V., Pignon J., Saint-Aubert B., et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. Clin Oncol J (Meeting abstracts) 2007, 25(Suppl 18):4510.
164. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy vs surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355(1):11-20.
165. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007, 8(3):226-234.
166. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335(7):462-467.
167. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation vs surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001, 19(2):305-313.
168. Tepper J., Krasna M.J., Niedzwiecki D., et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008, 26(7):1086-1092.
169. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992, 16(6):1104-1109. Discussion 1110.
170. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337(3):161-167.
171. Urschel J.D., Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185(6):538-543.
172. Bonnetain F., Bouche O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006, 17(5):827-834.
173. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003, 21(24):4592-4596.
174. Armanios M., Xu R., Forastiere A.A., et al. Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group. J Clin Oncol 2004, 22(22):4495-4499.
175. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001, 345(10):725-730.
176. Bedard E.L., Inculet R.I., Malthaner R.A., et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001, 91(12):2423-2430.
177. Rice T.W., Adelstein D.J., Chidel M.A., et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003, 126(5):1590-1596.
178. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
179. Ra J., Paulson E.C., Kucharczuk J., et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 2008, 15(6):1577-1584.
180. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977, 297(16):845-850.
181. Schroder W., Bollschweiler E., Kossow C., et al. Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy?. Langenbecks Arch Surg 2006, 391(5):455-460.
182. Ryan A.M., Hearty A., Prichard R.S., et al. Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. J Gastrointest Surg 2007, 11(10):1355-1360.
183. Lewis I. Carcinoma of the oesophagus. Radical resection with oesophagogastrotomy for a midthoracic growth by a right transpleural approach. J R Soc Med 1945, 38:482-483.
184. Sweet R.H. The treatment of carcinoma of the esophagus and cardiac end of the stomach by surgical extirpation: 203 cases of resection. Surgery 1948, 23(6):952-975.
185. Garlock J.H., Klein S.H. The surgical treatment of carcinoma of the esophagus and cardia; an analysis of 457 cases. Ann Surg 1954, 139(1):19-34.
186. Lee R.B., Miller J.I. Esophagectomy for cancer. Surg Clin North Am 1997, 77(5):1169-1196.
187. Collard J.M., Lengele B., Otte J.B., et al. En bloc and standard esophagectomies by thoracoscopy. Ann Thorac Surg 1993, 56(3):675-679.
188. Akaishi T., Kaneda I., Higuchi N., et al. Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg 1996, 112(6):1533-1540. Discussion 1540-1.
189. Dexter S.P., Martin I.G., McMahon M.J. Radical thoracoscopic esophagectomy for cancer. Surg Endosc 1996, 10(2):147-151.
190. Law S., Fok M., Chu K.M., et al. Esophagectomy for esophageal cancer. Surgery 1997, 122(1):8-14.
191. Liu H.P., Chang C.H., Lin P.J., et al. Video-assisted endoscopic esophagectomy with stapled intrathoracic esophagogastric anastomosis. World J Surg 1995, 19(5):745-747.
192. Luketich J.D., Nguyen N.T., Weigel T., et al. Minimally invasive approach to esophagectomy. JSLS 1998, 2(3):243-247.
193. Luketich J.D., Schauer P.R., Christie N.A., et al. Minimally invasive esophagectomy. Ann Thorac Surg 2000, 70(3):906-911. Discussion 911-2.
194. Fernando H.C., Christie N.A., Luketich J.D. Thoracoscopic and laparoscopic esophagectomy. Semin Thorac Cardiovasc Surg 2000, 12(3):195-200.
195. Nguyen N.T., Schauer P.R., Luketich J.D. Combined laparoscopic and thoracoscopic approach to esophagectomy. J Am Coll Surg 1999, 188(3):328-332.
196. Palanivelu C., Prakash A., Senthilkumar R., et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 2006, 203(1):7-16.
197. Akiyama H., Tsurumaru M., Kawamura T., et al. Esophageal stripping with preservation of the vagus nerve. Int Surg 1982, 67(2):125-128.
198. Banki F., Mason R.J., DeMeester S.R., et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002, 236(3):324-335. Discussion 335-6.
199. Peyre C.G., DeMeester S.R., Rizzetto C., et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 2007, 246(4):665-671. Discussion 671-4.
200. Jeyasingham K., Lerut T., Belsey R.H. Functional and mechanical sequelae of colon interposition for benign oesophageal disease. Eur J Cardiothorac Surg 1999, 15(3):327-331. Discussion 331-2.
201. Ventemiglia R., Khalil K.G., Frazier O.H., et al. The role of preoperative mesenteric arteriography in colon interposition. J Thorac Cardiovasc Surg 1977, 74(1):98-104.
202. Postlethwait R.W. Colonic interposition for esophageal substitution. Surg Gynecol Obstet 1983, 156(3):377-383.
203. Roux C. L'oesophago-jejuno-gastroneme: nouvelle operation pour retrecissement infranchissable de l'oesophage. Sem Med (Paris) 1907, 27:34-40.
204. Ascioti A.J., Hofstetter W.L., Miller M.J., et al. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 2005, 130(5):1391-1398.
205. Gaissert H.A., Mathisen D.J., Grillo H.C., et al. Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 1993, 106(5):860-866. Discussion 866-7.
206. Carrell A. The surgery of blood vessels etc. Johns Hopkins Hosp Bull 1907, 90:18-28.
207. Shangold L.M., Urken M.L., Lawson W. Jejunal transplantation for pharyngoesophageal reconstruction. Otolaryngol Clin North Am 1991, 24(6):1321-1342.
208. Disa J.J., Pusic A.L., Hidalgo D.A., et al. Microvascular reconstruction of the hypopharynx: defect classification, treatment algorithm, and functional outcome based on 165 consecutive cases. Plast Reconstr Surg 2003, 111(2):652-660. Discussion 661-3.
209. Mendenhall W.M., Sombeck M.D., Parsons J.T., et al. Management of cervical esophageal carcinoma. Semin Radiat Oncol Jul 1994, 4(3):179-191.
210. Siewert J.R., Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998, 85(11):1457-1459.
211. Ochsner A., Debakey M. Surgical aspects of carcinoma of the esophagus: review of the literature and report of four cases. J Thorac Cardiovasc Surg 1941, 10:401-445.
212. Earlam R., Cunha-Melo J.R. Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 1980, 67(6):381-390.
213. Muller J.M., Erasmi H., Stelzner M., et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990, 77(8):845-857.
214. Casson A.G., van Lanschot J.J. Improving outcomes after esophagectomy: the impact of operative volume. J Surg Oncol 2005, 92(3):262-266.
215. Schuchert M.J., Luketich J.D., Fernando H.C. Video-assisted thoracic surgery. Surgery: Basic Science and Clinical Evidence 2008, 1535-1549. Science and Business Media, Springer. 2nd edition. J.A. Norton, B.S. Barie, R.R. Bolliger (Eds.).
216. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346(15):1128-1137.
217. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349(22):2117-2127.
218. Boudourakis L.D., Wang T.S., Roman S.A., et al. Evolution of the surgeon-volume, patient-outcome relationship. Ann Surg 2009, 250(1):159-165.
219. Birkmeyer J.D., Sun Y., Wong S.L., et al. Hospital volume and late survival after cancer surgery. Ann Surg 2007, 245(5):777-783.
220. Dimick J.B., Goodney P.P., Orringer M.B., et al. Specialty training and mortality after esophageal cancer resection. Ann Thorac Surg 2005, 80(1):282-286.
221. Waljee J.F., Greenfield L.J., Dimick J.B., et al. Surgeon age and operative mortality in the United States. Ann Surg 2006, 244(3):353-362.
222. Miller J.D., Jain M.K., de Gara C.J., et al. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol 1997, 65(1):20-21.
223. Lerut T., Coosemans W., Decker G., et al. Surgical techniques. J Surg Oncol 2005, 92(3):218-229.
224. Waterman T.A., Hagen J.A., Peters J.H., et al. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 2004, 78(4):1161-1169. Discussion 1161-9.
225. Rizk N., Venkatraman E., Park B., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006, 132(6):1374-1381.
226. Hofstetter W., Correa A.M., Bekele N., et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 2007, 84(2):365-373. Discussion 374-5.
227. Rizk N.P., Bach P.B., Schrag D., et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 2004, 198(1):42-50.
228. Chang A.C., Ji H., Birkmeyer N.J., et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008, 85(2):424-429.
229. Connors R.C., Reuben B.C., Neumayer L.A., et al. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 2007, 205(6):735-740.
230. Rindani R., Martin C.J., Cox M.R. Transhiatal vs Ivor-Lewis oesophagectomy: is there a difference?. Aust NZ J Surg 1999, 69(3):187-194.
231. Hulscher J.B., Tijssen J.G., Obertop H., et al. Transthoracic vs transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001, 72(1):306-313.
232. Goldminc M., Maddern G., Le Prise E., et al. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993, 80(3):367-370.
233. Chu K.M., Law S.Y., Fok M., et al. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997, 174(3):320-324.
234. Jacobi C.A., Zieren H.U., Muller J.M., et al. Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg 1997, 11(1):32-37.
235. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347(21):1662-1669.
236. Morgan M.A., Lewis W.G., Hopper A.N., et al. Prospective comparison of transthoracic vs transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus 2007, 20(3):225-231.
237. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000. Discussion 1000-1.
238. Logan A. The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg 1963, 46:150-161.
239. Skinner D.B. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983, 85(1):59-71.
240. Altorki N., Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 2001, 234(5):581-587.
241. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg Oct 2001, 234(4):520-530. Discussion 530-1.
242. Altorki N.K., Girardi L., Skinner D.B. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg Dec 1997, 114(6):948-955. Discussion 955-6.
243. Isono K., Sato H., Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991, 48(5):411-420.
244. Altorki N., Kent M., Ferrara C., et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002, 236(2):177-183.
245. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg Dec 2004, 240(6):962-972. Discussion 972-4.
246. Peyre C.G., Hagen J.A., DeMeester S.R., et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008, 248(4):549-556.
247. Swanson S.J., Sugarbaker D.J. The three-hole esophagectomy. The Brigham and Women's Hospital approach (modified McKeown technique). Chest Surg Clin N Am 2000, 10(3):531-552.
248. Orringer M.B., Marshall B., Iannettoni M.D. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000, 119(2):277-288.
249. Ercan S., Rice T.W., Murthy S.C., et al. Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer?. J Thorac Cardiovasc Surg 2005, 129(3):623-631.
250. Santos R.S., Raftopoulos Y., Singh D., et al. Utility of total mechanical stapled cervical esophagogastric anastomosis after esophagectomy: a comparison to conventional anastomotic techniques. Surgery 2004, 136(4):917-925.
251. Singh D., Maley R.H., Santucci T., et al. Experience and technique of stapled mechanical cervical esophagogastric anastomosis. Ann Thorac Surg 2001, 71(2):419-424.
252. Luketich J.D., Landreneau R.J. Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer. J Gastrointest Surg 2004, 8(8):927-929.
253. Behzadi A., Nichols F.C., Cassivi S.D., et al. Esophagogastrectomy: the influence of stapled vs hand-sewn anastomosis on outcome. J Gastrointest Surg 2005, 9(8):1031-1040. Discussion 1040-2.
254. Craig S.R., Walker W.S., Cameron E.W., et al. A prospective randomized study comparing stapled with handsewn oesophagogastric anastomoses. J R Coll Surg Edinb 1996, 41(1):17-19.
255. Law S., Fok M., Chu K.M., et al. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 1997, 226(2):169-173.
256. Blackmon S.H., Correa A.M., Wynn B., et al. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 2007, 83(5):1805-1813. Discussion 1813.
257. Urschel J.D., Blewett C.J., Bennett W.F., et al. Handsewn or stapled esophagogastric anastomoses after esophagectomy for cancer: meta-analysis of randomized controlled trials. Dis Esophagus 2001, 14(3-4):212-217.
258. Collard J.M., Romagnoli R., Goncette L., et al. Semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg 1998, 65(3):814-817.
259. Collard J.M. The stomach as an esophageal substitute after total or subtotal esophagectomy: comparison between the gastric tube and the whole stomach 1997, [thesis], Université Catholique de Louvain, Brussels, Belgium.
260. Schuchert M.J., Pettiford B.L., Landreneau J.P., et al. Transcervical gastric tube drainage facilitates patient mobility and reduces the risk of pulmonary complications after esophagectomy. J Gastrointest Surg 2008, 12(9):1479-1484.
261. Kent M.S., Awais O., Schuchert M.J., et al. Cervical pharyngostomy: an old technique revisited. Ann Surg 2008, 248(2):199-204.
262. Whooley B.P., Law S., Alexandrou A., et al. Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer. Am J Surg 2001, 181(3):198-203.
263. Martin L.W., Swisher S.G., Hofstetter W., et al. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 2005, 242(3):392-399. Discussion 399-402.
264. Bussieres J.S. Open or minimally invasive esophagectomy: are the outcomes different?. Curr Opin Anaesthesiol 2009, 22(1):56-60.
265. Gossot D., Cattan P., Fritsch S., et al. Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?. Surg Endosc 1995, 9(10):1113-1115.
266. Peracchia A., Rosati R., Fumagalli U., et al. Esophagectomy: are there benefits?. Semin Surg Oncol 1997, 13(4):259-262.
267. Smithers B.M., Gotley D.C., McEwan D., et al. Thoracoscopic mobilization of the esophagus. A 6 year experience. Surg Endosc 2001, 15(2):176-182.
268. Osugi H., Takemura M., Higashino M., et al. Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 2003, 17(3):515-519.
269. Jagot P., Sauvanet A., Berthoux L., et al. Laparoscopic mobilization of the stomach for oesophageal replacement. Br J Surg 1996, 83(4):540-542.
270. Gerhart C.D. Hand-assisted laparoscopic transhiatal esophagectomy using the dexterity pneumo sleeve. JSLS 1998, 2(3):295-298.
271. Bodner J., Wykypiel H., Wetscher G., et al. First experiences with the da Vinci operating robot in thoracic surgery. Eur J Cardiothorac Surg 2004, 25(5):844-851.
272. Horgan S., Berger R.A., Elli E.F., et al. Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 2003, 69(7):624-626.
273. Ikeda Y., Niimi M., Kan S., et al. Mediastinoscopic esophagectomy using carbon dioxide insufflation via the neck approach. Surgery 2001, 129(4):504-506.
274. Watson D.I., Davies N., Jamieson G.G. Totally endoscopic Ivor Lewis esophagectomy. Surg Endosc 1999, 13(3):293-297.
275. Nguyen N.T., Roberts P., Follette D.M., et al. Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 2003, 197(6):902-913.
276. Bizekis C., Kent M.S., Luketich J.D., et al. Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 2006, 82(2):402-406. Discussion 406-7.
277. Gemmill E.H., McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007, 94(12):1461-1467.
278. Shiraishi T., Kawahara K., Shirakusa T., et al. Risk analysis in resection of thoracic esophageal cancer in the era of endoscopic surgery. Ann Thorac Surg 2006, 81(3):1083-1089.
279. Schuchert M.J., Luketich J.D., Fernando H.C. Complications of minimally invasive esophagectomy. Semin Thorac Cardiovasc Surg 2004, 16(2):133-141.
280. Nguyen N.T., Follette D.M., Wolfe B.M., et al. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg 2000, 135(8):920-925.
281. Bresadola V., Terrosu G., Cojutti A., et al. Laparoscopic vs open gastroplasty in esophagectomy for esophageal cancer: a comparative study. Surg Laparosc Endosc Percutan Tech 2006, 16(2):63-67.
282. Donington J.S. Functional conduit disorders after esophagectomy. Thorac Surg Clin 2006, 16(1):53-62.
283. Young M.M., Deschamps C., Allen M.S., et al. Esophageal reconstruction for benign disease: self-assessment of functional outcome and quality of life. Ann Thorac Surg 2000, 70(6):1799-1802.
284. McLarty A.J., Deschamps C., Trastek V.F., et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997, 63(6):1568-1572.
285. Williams V.A., Watson T.J., Herbella F.A., et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007, 11(12):1589-1597.
286. Kent M.S., Luketich J.D., Tsai W., et al. Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg 2008, 86(3):975-983. Discussion 967-74.
287. Kent M.S., Pennathur A., Fabian T., et al. A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy. Surg Endosc 2007, 21(5):754-757.
288. Fell S.C., Kirby T. Volvulus of the intrathoracic stomach after total esophagectomy. J Thorac Cardiovasc Surg 1991, 102(4):640-641.
289. Casson A.G., Inculet R., Finley R. Volvulus of the intrathoracic stomach after total esophagectomy. J Thorac Cardiovasc Surg 1990, 100(4):633-634.
290. Headrick J.R., Nichols F.C., Miller D.L., et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002, 73(6):1697-1702. Discussion 1702-3.
291. Chang L.C., Oelschlager B.K., Quiroga E., et al. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 2006, 10(3):341-346.
292. de Boer A.G., van Lanschot J.J., van Sandick J.W., et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004, 22(20):4202-4208.
293. Blazeby J.M., Farndon J.R., Donovan J., et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000, 88(8):1781-1787.
294. Javle M., Ailawadhi S., Yang G.Y., et al. Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol 2006, 4(8):365-373.
295. Weigel T.L., Frumiento C., Gaumintz E. Endoluminal palliation for dysphagia secondary to esophageal carcinoma. Surg Clin North Am 2002, 82(4):747-761.
296. Orringer M.B., Sloan H. Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma. J Thorac Cardiovasc Surg 1975, 70(5):836-851.
297. Orringer M.B. Substernal gastric bypass of the excluded esophagus-results of an ill-advised operation. Surgery 1984, 96(3):467-470.
298. Christie N.A., Buenaventura P.O., Fernando H.C., et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg 2001, 71(6):1797-1801. Discussion 1801-2.
299. Litle V.R., Luketich J.D., Christie N.A., et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 2003, 76(5):1687-1692. Discussion 1692-3.
300. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfimer sodium vs thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995, 42(6):507-512.
301. Homs M.Y., Essink-Bot M.L., Borsboom G.J., et al. Quality of life after palliative treatment for oesophageal carcinoma-a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004, 40(12):1862-1871.
302. da Silveira E.B., Artifon E.L. Cost-effectiveness of palliation of unresectable esophageal cancer. Dig Dis Sci 2008, 53(12):3103-3111.
303. Watson D.I., Jamieson G.G., Devitt P.G. Endoscopic cervico-thoraco-abdominal esophagectomy. J Am Coll Surg 2000, 190(3):372-378.
304. Kawahara K., Maekawa T., Okabayashi K., et al. Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc 1999, 13(3):218-223.
305. Swanson S.J., Batirel H.F., Bueno R., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001, 72(6):1918-1924. Discussion 1924-5.
306. Bailey S.H., Bull D.A., Harpole D.H., et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003, 75(1):217-222. Discussion 222.